How 1 drug is reshaping cancer care
When the FDA approved daraxonrasib for metastatic pancreatic cancer Aug. 26, some in oncology expected access to remain concentrated at academic medical centers. Nearly three months later, leaders at seven organizations say patients at many cancer centers, including community sites, are starting the drug within one to two weeks. Instead, the remaining access barriers have […] The post How 1 drug is reshaping cancer care appeared first on Becker's Hospital Review | Healthcare News &...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.